Keros Therapeutics, Inc. ($KROS)
Filing Information
| Accession Number | 0001221590-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
1,000
Total Value
$10,580.00
P&L
-1.6% ($170.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 15, 2026 | Purchase | 1,000 | $10.58 | $10,580.00 | 9,450 | Direct | โ | View Details |